Consistently with the analysis of subclinical characteristics of all analysed patients, the chronic group (CHB, LC, and HCC) showed significantly elevated values of ALT (113.0 vs 69.5 IU/l), AST (136.5 vs 75.0 IU/l), total bilirubin (44.7 vs 22.3 mg/dl), and direct bilirubin (21.3 vs 12.0 mg/dl) in the HDV-positive samples in comparison to HDV-negative samples (p<0.05) (Figure 4C and Table 5). Here, GPT is linked to hepatocellular carcinoma.